Cantargia AB has announced the immediate appointment of Morten Lind Jensen as Chief Medical Officer. He brings extensive experience in autoimmune and inflammatory disease treatments.
Company Information
Company
Cantargia
Location
27 Scheelevaegen
Lund, Skåne County, Sweden
About
Cantargia AB is a publicly traded biopharmaceutical company focused on the development of treatments for autoimmune and inflammatory diseases. The company works on innovative therapies leveraging its expertise in clinical development and regulatory strategies. It is dedicated to improving the quality of life for patients by addressing unmet medical needs.